Since its FDA approval in 2002, Atomoxetine (brand name Strattera) has become a second or third line option (after stimulants and sometimes after central alpha agonists) for ADHD in both children and adults. Does it work? Listen and find out!
It would be incredibly difficult to effectively manage both schizophrenia and autism without antipsychotics. The extensive research data and strong evidence of efficacy clearly supports the use of antipsychotics in these youth subpopulations. However, we start to run into some serious problems when we start using antipsychotics off-label in youth. We now have more information on the possible direct neurotoxicity of antipsychotic medications. How to sort through this and maximize the help while minimizing the risks?
https://www.thecarlatreport.com/podcast/do-antipsychotics-have-neurotoxic-effects-in-youth/
You Might Also Enjoy...
Since its FDA approval in 2002, Atomoxetine (brand name Strattera) has become a second or third line option (after stimulants and sometimes after central alpha agonists) for ADHD in both children and adults. Does it work? Listen and find out!
ADHD is one of the most treatable conditions in psychiatry if patients adhere to medication regimens. So, why are parents so resistant to stimulant medications and how can we approach these misconceptions?
Each year in the US, there are about 1.04 million divorces, affecting about 800,000 children. How can we navigate the complexities of treating a child with divorce?
With a growing body of evidence supporting its clinical efficacy and cost-effectiveness relative to traditional ABA approaches, the developmental model is being used with increasing prevalence across the US.
Prescribing Psychotropics bridges the gap between the complexities of drug pharmacokinetics and everyday clinical practice, providing clinicians more insight into how psychiatric drugs behave (or misbehave!) once their patients take them.
As leaders we want to be kind while being effective, and this can be difficult. How do make sure that we do not become tired and angry but instead stay fresh and creative? Hear Zoe Kernohan Neely, Josh Feder MD & Jerri Lynn Hogg PhD in three mini videos.